Adam David DeVore, MD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Clinical Research Institute 200 Morris Street, #6318, Durham, NC 27701
Phone (919) 668-8788
Email address adam.devore@duke.edu

Adam D. DeVore, MD, MHS

Dr. DeVore is a cardiologist and Assistant Professor of Medicine in the Department of Medicine, Division of Cardiology, at Duke University School of Medicine. His clinical interests include caring for patients and families with heart failure, including those with left ventricular assist devices and heart transplants. He is involved in and leads multiple large studies of patients with heart failure at both Duke University Medical Center and the Duke Clinical Research Institute. He currently serves as the assistant director of the Duke Heart Transplant program and the medical director for the Heart Failure Research Cluster.

He attended medical school at the University of Chicago Pritzker School of Medicine and completed internal medicine residency at Brigham and Women’s Hospital. He then pursued cardiology training at Duke University and solidified his interests in clinical research and heart failure. He completed a research fellowship at the Duke Clinical Research Institute and a Masters of Health Sciences in Clinical Research before completing an advanced heart failure fellowship at Duke University.

The overarching goals of his research are to advance the current understanding of heart failure through clinical trials as well as develop an evidence base for implementation strategies that addresses the gap between heart failure trial results and clinical practice. For example, he has served on the Steering Committees for large clinical trials, including PIONEER-HF and SPIRRIT-HFpEF. Dr. DeVore also published the first clinical trial conducted within the American Heart Association’s Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions. He is also the principal investigator for CONNECT-HF, a large-scale, pragmatic, cluster-randomized trial at 161 sites in the US evaluating heart failure quality improvement initiatives. Outside of his work on heart failure, Dr. DeVore is  married with 4 children and spends his time corralling them all and coaching Little League baseball.

 

 

In Their Words

Education and Training

  • Fellowship in Advanced Heart Failure, Medicine, Duke University School of Medicine, 2015 - 2016
  • Fellowship in Clinical Research, DCRI, Duke University School of Medicine, 2013 - 2015
  • Fellowship in Cardiovascular Medicine, Medicine, Duke University School of Medicine, 2011 - 2013
  • Internal Medicine Residency, Brigham and Women's Hospital, 2007 - 2010
  • M.D., University of Chicago, 2007

Publications

Schwartz, Gregory G., P Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Jay M. Edelberg, et al. “Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.” N Engl J Med 379, no. 22 (November 29, 2018): 2097–2107. https://doi.org/10.1056/NEJMoa1801174.

PMID
30403574
Full Text

Mulvihill, Michael S., Morgan L. Cox, Muath Bishawi, Asishana A. Osho, Babatunde A. Yerokun, Cameron R. Wolfe, Adam D. DeVore, et al. “Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation.” J Am Coll Cardiol 72, no. 19 (November 6, 2018): 2408–9. https://doi.org/10.1016/j.jacc.2018.07.097.

PMID
30384897
Full Text

Fudim, Marat, Kishan S. Parikh, Allison Dunning, Adam D. DeVore, Robert J. Mentz, Phillip J. Schulte, Paul W. Armstrong, et al. “Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).” Am J Cardiol 122, no. 9 (November 1, 2018): 1506–12. https://doi.org/10.1016/j.amjcard.2018.07.023.

PMID
30172362
Full Text

Hernandez, Adrian F., Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, et al. “Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.” Lancet 392, no. 10157 (October 27, 2018): 1519–29. https://doi.org/10.1016/S0140-6736(18)32261-X.

PMID
30291013
Full Text

Warraich, Haider J., Haolin Xu, Adam D. DeVore, Roland Matsouaka, Paul A. Heidenreich, Deepak L. Bhatt, Adrian F. Hernandez, Clyde W. Yancy, Gregg C. Fonarow, and Larry A. Allen. “Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry.” Jama Cardiol 3, no. 10 (October 1, 2018): 917–26. https://doi.org/10.1001/jamacardio.2018.2678.

PMID
30167645
Full Text

Bhatt, Ankeet S., Li Liang, Adam D. DeVore, Gregg C. Fonarow, Scott D. Solomon, Orly Vardeny, Clyde W. Yancy, et al. “Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure.” Jacc Heart Fail 6, no. 10 (October 2018): 844–55. https://doi.org/10.1016/j.jchf.2018.04.012.

PMID
30098960
Full Text

McHugh, Kelly R., Adam D. DeVore, Robert J. Mentz, Daniel Edmonston, Jennifer B. Green, and Adrian F. Hernandez. “The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.” Clin Cardiol 41, no. 9 (September 2018): 1259–67. https://doi.org/10.1002/clc.23054.

PMID
30125365
Full Text

DeVore, Adam D., C Larry Hill, Laine Thomas, Puza P. Sharma, Nancy M. Albert, Javed Butler, J Herbert Patterson, et al. “Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.” Circ Heart Fail 11, no. 9 (September 2018): e005400. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005400.

PMID
30354360
Full Text

Washam, Jeffrey B., Babatunde Yerokun, Chetan B. Patel, Ian J. Welsby, Carmelo A. Milano, and Adam D. DeVore. “Cangrelor use prior to left ventricular assist device surgery: a case series.” J Thromb Thrombolysis 46, no. 2 (August 2018): 131–33. https://doi.org/10.1007/s11239-018-1691-5.

PMID
29860606
Full Text

Pages